BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 12666108)

  • 1. Of mice and men: reconciling preclinical ALS mouse studies and human clinical trials.
    Rothstein JD
    Ann Neurol; 2003 Apr; 53(4):423-6. PubMed ID: 12666108
    [No Abstract]   [Full Text] [Related]  

  • 2. Guidelines for the preclinical in vivo evaluation of pharmacological active drugs for ALS/MND: report on the 142nd ENMC international workshop.
    Ludolph AC; Bendotti C; Blaugrund E; Hengerer B; Löffler JP; Martin J; Meininger V; Meyer T; Moussaoui S; Robberecht W; Scott S; Silani V; Van Den Berg LH;
    Amyotroph Lateral Scler; 2007 Aug; 8(4):217-23. PubMed ID: 17653919
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Animal models of amyotrophic lateral sclerosis].
    Yamanaka K
    Rinsho Shinkeigaku; 2007 Nov; 47(11):934-7. PubMed ID: 18210840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selecting promising ALS therapies in clinical trials.
    Glass JD; Benatar M; Polak M
    Neurology; 2007 May; 68(18):1545-6; author reply 1546. PubMed ID: 17470765
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of p75 neurotrophin receptor antagonist on disease progression in transgenic amyotrophic lateral sclerosis mice.
    Turner BJ; Murray SS; Piccenna LG; Lopes EC; Kilpatrick TJ; Cheema SS
    J Neurosci Res; 2004 Oct; 78(2):193-9. PubMed ID: 15378612
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Animal models of amyotrophic lateral sclerosis.
    Mitsumoto H; Pioro EP
    Adv Neurol; 1995; 68():73-87; discussion 89-91. PubMed ID: 8787246
    [No Abstract]   [Full Text] [Related]  

  • 7. [Experimental models of amyotrophic lateral sclerosis].
    Galán L; Vela A; Guerrero A; Barcia JA; García-Verdugo JM; Matias-Guiu J
    Neurologia; 2007; 22(6):381-8. PubMed ID: 17610166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined immunosuppressive agents or CD4 antibodies prolong survival of human neural stem cell grafts and improve disease outcomes in amyotrophic lateral sclerosis transgenic mice.
    Yan J; Xu L; Welsh AM; Chen D; Hazel T; Johe K; Koliatsos VE
    Stem Cells; 2006 Aug; 24(8):1976-85. PubMed ID: 16644922
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Skeletal muscle in amyotrophic lateral sclerosis: emerging concepts and therapeutic implications.
    Abmayr S; Weydt P
    Phys Med Rehabil Clin N Am; 2005 Nov; 16(4):1091-7, xi-xii. PubMed ID: 16214062
    [No Abstract]   [Full Text] [Related]  

  • 10. Regular exercise is beneficial to a mouse model of amyotrophic lateral sclerosis.
    Kirkinezos IG; Hernandez D; Bradley WG; Moraes CT
    Ann Neurol; 2003 Jun; 53(6):804-7. PubMed ID: 12783429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is prostaglandin E(2) a pathogenic factor in amyotrophic lateral sclerosis?
    Almer G; Kikuchi H; Teismann P; Przedborski S
    Ann Neurol; 2006 Jun; 59(6):980-3. PubMed ID: 16619237
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altered distributions of nucleocytoplasmic transport-related proteins in the spinal cord of a mouse model of amyotrophic lateral sclerosis.
    Zhang J; Ito H; Wate R; Ohnishi S; Nakano S; Kusaka H
    Acta Neuropathol; 2006 Dec; 112(6):673-80. PubMed ID: 16957927
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of amyotrophic lateral sclerosis - what is the next step?
    Ludolph AC
    J Neurol; 2000 Dec; 247 Suppl 6():VI/13-8. PubMed ID: 19714403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of transplantation of wild-type bone marrow stem cells in mouse model of familial amyotrophic lateral sclerosis].
    Huang H; Zhang C; Zhao CP; Yao XL; Xi J
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2006 Aug; 28(4):562-6. PubMed ID: 16995314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transgenic-mouse model of amyotrophic lateral sclerosis.
    Gurney ME
    N Engl J Med; 1994 Dec; 331(25):1721-2. PubMed ID: 7832899
    [No Abstract]   [Full Text] [Related]  

  • 16. New ideas for therapy in ALS: critical considerations.
    Beghi E; Bendotti C; Mennini T
    Amyotroph Lateral Scler; 2006 Jun; 7(2):126-7; discussion 127. PubMed ID: 16753979
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of environmental enrichment on the amyotrophic lateral sclerosis mouse model.
    Sorrells AD; Corcoran-Gomez K; Eckert KA; Fahey AG; Hoots BL; Charleston LB; Charleston JS; Roberts CR; Markowitz H
    Lab Anim; 2009 Apr; 43(2):182-90. PubMed ID: 19246505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Of Mouse Models and Men.
    Williams DA
    Mol Ther; 2007 Apr; 15(4):643. PubMed ID: 28192701
    [No Abstract]   [Full Text] [Related]  

  • 19. Establishment of autaptic culture with human-induced pluripotent stem cell-derived astrocytes.
    Uchino K; Tanaka Y; Kawaguchi S; Kubota K; Watanabe T; Katsurabayashi S; Hirose S; Iwasaki K
    iScience; 2022 Aug; 25(8):104762. PubMed ID: 35942096
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent Technical Advances in Accelerating the Clinical Translation of Small Animal Brain Imaging: Hybrid Imaging, Deep Learning, and Transcriptomics.
    Ren W; Ji B; Guan Y; Cao L; Ni R
    Front Med (Lausanne); 2022; 9():771982. PubMed ID: 35402436
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.